Literature DB >> 31702968

Bimodal right ventricular dysfunction after postnatal hyperoxia exposure: implications for the preterm heart.

Santosh Kumari1, Rudolf K Braun2, Laura H Tetri2, Gregory P Barton2, Timothy A Hacker3, Kara N Goss1,2.   

Abstract

Rats exposed to postnatal hyperoxia develop right ventricular (RV) dysfunction, mild pulmonary hypertension, and dysregulated cardiac mitochondrial biogenesis when aged to one year, with the degree of cardiac dysfunction and pulmonary hypertension similar to that previously described in young adults born preterm. Here, we sought to understand the impact of postnatal hyperoxia exposure on RV hemodynamic and mitochondrial function across the life span. In Methods, pups from timed-pregnant Sprague-Dawley rats were randomized to normoxia or hyperoxia [fraction of inspired oxygen (FIO2), 0.85] exposure for the first 14 days of life, a commonly used model of chronic lung disease of prematurity. RV hemodynamic and mitochondrial function were assessed by invasive measurement of RV pressure-volume loops and by high-resolution respirometry at postnatal day 21 (P21), P90, and P365. In Results, at P21, hyperoxia-exposed rats demonstrated severe pulmonary hypertension and RV dysfunction, accompanied by depressed mitochondrial oxidative capacity. However, significant upregulation of mitochondrial biogenesis at P21 as well as improved afterload led to complete RV hemodynamic and mitochondrial recovery at P90. Mitochondrial DNA mutations were significantly higher by P90 and associated with significant late RV mitochondrial and hemodynamic dysfunction at P365. In conclusion, there appears to be a "honeymoon period" where cardiac hemodynamic and mitochondrial function normalizes following postnatal hyperoxia exposure, only to decline again with ongoing aging. This finding may have significant implications if a long-term pulmonary vascular screening program were to be developed for children or adults with a history of severe prematurity. Further investigation into the mechanisms of recovery are warranted.NEW & NOTEWORTHY Premature birth is associated with increased risk for cardiac dysfunction and failure throughout life. Here, we identify bimodal right ventricular dysfunction after postnatal hyperoxia exposure. Mitochondrial biogenesis serves as an early adaptive feature promoting recovery of cardiac hemodynamic and mitochondrial function. However, the accumulation of mitochondrial DNA mutations results in late mitochondrial and right ventricular dysfunction. This bimodal right ventricular dysfunction may have important implications for the development of screening programs in the preterm population.

Entities:  

Keywords:  heart failure; mitochondria; pediatric; prematurity; pulmonary hypertension

Mesh:

Substances:

Year:  2019        PMID: 31702968      PMCID: PMC6962619          DOI: 10.1152/ajpheart.00383.2019

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  40 in total

Review 1.  Mitochondrial threshold effects.

Authors:  Rodrigue Rossignol; Benjamin Faustin; Christophe Rocher; Monique Malgat; Jean-Pierre Mazat; Thierry Letellier
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

2.  Analysis of mitochondrial function in situ in permeabilized muscle fibers, tissues and cells.

Authors:  Andrey V Kuznetsov; Vladimir Veksler; Frank N Gellerich; Valdur Saks; Raimund Margreiter; Wolfram S Kunz
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

3.  Multiscale structure-function relationships in right ventricular failure due to pressure overload.

Authors:  Tik-Chee Cheng; Jennifer L Philip; Diana M Tabima; Timothy A Hacker; Naomi C Chesler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-06-08       Impact factor: 4.733

4.  Pulmonary Artery Pressures in School-Age Children Born Prematurely.

Authors:  Sanja Zivanovic; Kuberan Pushparajah; Sandy Calvert; Neil Marlow; Reza Razavi; Janet L Peacock; Anne Greenough
Journal:  J Pediatr       Date:  2017-12       Impact factor: 4.406

5.  Early Pulmonary Vascular Disease in Young Adults Born Preterm.

Authors:  Kara N Goss; Arij G Beshish; Gregory P Barton; Kristin Haraldsdottir; Taylor S Levin; Laura H Tetri; Therese J Battiola; Ashley M Mulchrone; David F Pegelow; Mari Palta; Luke J Lamers; Andrew M Watson; Naomi C Chesler; Marlowe W Eldridge
Journal:  Am J Respir Crit Care Med       Date:  2018-12-15       Impact factor: 21.405

6.  Pulmonary hypertension in preterm infants with bronchopulmonary dysplasia.

Authors:  Hyo Soon An; Eun Jung Bae; Gi Beom Kim; Bo Sang Kwon; Jae Suk Beak; Ee Kyung Kim; Han Suk Kim; Jung-Hwan Choi; Chung Il Noh; Yong Soo Yun
Journal:  Korean Circ J       Date:  2010-03-24       Impact factor: 3.243

7.  Cardiovascular consequences of bronchopulmonary dysplasia in prematurely born preschool children.

Authors:  Ozge Altun Koroglu; Mehmet Yalaz; Erturk Levent; Mete Akisu; Nilgun Kültürsay
Journal:  Neonatology       Date:  2013-09-30       Impact factor: 4.035

Review 8.  Animal models of bronchopulmonary dysplasia. The term rat models.

Authors:  Megan O'Reilly; Bernard Thébaud
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-10-10       Impact factor: 5.464

9.  Mitochondrial biogenesis restores oxidative metabolism during Staphylococcus aureus sepsis.

Authors:  Douglas W Haden; Hagir B Suliman; Martha Sue Carraway; Karen E Welty-Wolf; Abdelwahid S Ali; Hiroshi Shitara; Hiromichi Yonekawa; Claude A Piantadosi
Journal:  Am J Respir Crit Care Med       Date:  2007-06-28       Impact factor: 21.405

10.  The Preterm Heart in Childhood: Left Ventricular Structure, Geometry, and Function Assessed by Echocardiography in 6-Year-Old Survivors of Periviable Births.

Authors:  Lilly-Ann Mohlkert; Jenny Hallberg; Olof Broberg; Annika Rydberg; Cecilia Pegelow Halvorsen; Petru Liuba; Vineta Fellman; Magnus Domellöf; Gunnar Sjöberg; Mikael Norman
Journal:  J Am Heart Assoc       Date:  2018-01-20       Impact factor: 5.501

View more
  7 in total

Review 1.  Hemodynamic assessment of diastolic function for experimental models.

Authors:  Leslie M Ogilvie; Brittany A Edgett; Jason S Huber; Mathew J Platt; Hermann J Eberl; Sohrab Lutchmedial; Keith R Brunt; Jeremy A Simpson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-03-27       Impact factor: 4.733

2.  Autophagy, TERT, and mitochondrial dysfunction in hyperoxia.

Authors:  Andreas M Beyer; Laura E Norwood Toro; William E Hughes; Micaela Young; Anne V Clough; Feng Gao; Meetha Medhora; Said H Audi; Elizabeth R Jacobs
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-09-24       Impact factor: 4.733

3.  Reply to Tello et al.: Pending Right Heart Failure in Healthy Preterm-Born Subjects?

Authors:  Alessandro Bellofiore; Kara N Goss; Ashley Mulchrone; Naomi C Chesler
Journal:  Am J Respir Crit Care Med       Date:  2020-04-15       Impact factor: 21.405

4.  Exercise and hypoxia unmask pulmonary vascular disease and right ventricular dysfunction in a 10- to 12-week-old swine model of neonatal oxidative injury.

Authors:  Jarno J Steenhorst; Alexander Hirsch; Annemarie Verzijl; Piotr Wielopolski; Daphne de Wijs-Meijler; Dirk J Duncker; Irwin K M Reiss; Daphne Merkus
Journal:  J Physiol       Date:  2022-08-11       Impact factor: 6.228

5.  Increased mitochondrial oxygen consumption in adult survivors of preterm birth.

Authors:  Santosh Kumari; Gregory P Barton; Kara N Goss
Journal:  Pediatr Res       Date:  2021-02-22       Impact factor: 3.756

6.  Impact of the Vulnerable Preterm Heart and Circulation on Adult Cardiovascular Disease Risk.

Authors:  Adam J Lewandowski; Philip T Levy; Melissa L Bates; Patrick J McNamara; Anne Monique Nuyt; Kara N Goss
Journal:  Hypertension       Date:  2020-08-17       Impact factor: 10.190

7.  Exaggerated Cardiac Contractile Response to Hypoxia in Adults Born Preterm.

Authors:  Gregory P Barton; Philip A Corrado; Christopher J Francois; Naomi C Chesler; Marlowe W Eldridge; Oliver Wieben; Kara N Goss
Journal:  J Clin Med       Date:  2021-03-10       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.